MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C.

robot
Abstract generation in progress

Bragar Eagel & Squire, P.C. announced a class-action lawsuit against Mereo BioPharma Group plc (NASDAQ:MREO) on behalf of investors who purchased shares between June 5, 2023, and December 26, 2025. The lawsuit alleges that Mereo made misleading statements regarding the Phase 3 ORBIT and COSMIC studies for setrusumab, which ultimately failed to meet their primary endpoints, causing a significant stock price decline. Investors have until April 6, 2026, to apply to be lead plaintiff.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin